Investing

The funding round comes one month after the company announced it secured a $35 million investment.

The company will use the funds for the global introduction of its robotic retinal imaging, AI and teleophthalmology platform.

The funds will be used to expand the company's reach with payers and providers, grow its team and for product development.

The company is on track to be live in 10 U.S. states by the end of 2025.

Dr. Atul Gupta, CMO of diagnosis and treatment at Philips, and Kevin Roesch, assistant VP of cardiology and imaging services for Methodist Hospitals, highlight the process of developing interventional labs to support Indiana’s residents.

The company will use the funds to improve its value-based care model, including its AI and analytics tools, and expand its partnerships and services.

Also, Indian e-pharmacy PlatinumRx has raised $6 million in Series A funding for its expansion.

The company's AI platform schedules patient appointments and fields questions 24/7.

The company will use the funding to further develop its SmartShunt System, aimed at reducing shunt failures and improving care for patients with hydrocephalus.

Also, Singapore has approved a lung cancer imaging AI platform.